Tom Flynn - Profile and Investment Details

Investor Profile

Tom Flynn is a Venture Capital, Investor based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide, myOrthos, CSA Medical, Avitide, Sutro BiopharmaHealth Essentials Holdings, CardioFocus, TopiVert, Aligned TeleHealth, LOQUS23 THERAPEUTICS, CytoMed Therapeutics, Bicycle Therapeutics, Jet Health, Genova Diagnostics, Inc., Centauri Health Solutions, PanOptica, Halscion, Inc., Urgent Team Holdings, Inc., Arsanis, Atopix Therapeutics, Bardy Diagnostics, EBT Medical, Urgent Team Family & Urgent Care, Cibiem, Inc., CardioKinetix, Amwell, Avrobio, NKT Therapeutics, Pionyr Immunotherapeutics, Healthify, Zarodex Therapeutics, Misonix, Sitryx Therapeutics, KalVista Pharmaceuticals, PHNS, Good Start Genetics, Aerocare Holdings, Cerevance, Karus Therapeutics, MedPointe, Ribometrix, Transposon Therapeutics, Spinal Kinetics, Catamaran Bio, Thesan Pharmaceuticals, Autifony Therapeutics, ReShape Lifesciences, Leiter's, Schweiger Dermatology Group, Artios Pharma, Leiters, Endotronix, Maestro Health, EBR Systems, ValenTx, AllianceCare, Xilio Therapeutics, Evidation Health, SUN Behavioral Health, Nordic Consulting Partners, Inc., Caraway Therapeutics, Soffio Medical, Zerigo Health, Amerita, Inc., VHSquared, AqueSys, Doctors of Physical Therapy, AcuFocus, Physicians Dialysis, Cellinta, Schweiger Dermatology, Deciphera Pharmaceuticals, Delenex Therapeutics, . Over time, Tom Flynn has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Tom Flynn is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Genetics, Wellness, Women Founded, Life Science, Payment Processing, Information Services, Analytics, Technology, Finance, Biotechnology, Electronic Health Records (EHR), Genomics, Health and Hospital Services, Clinical Trials, B2C, Health Diagnostics, Digital Health, Developer Tools, Medical, Big Data, B2B, Therapeutics, Healthcare Payments, Pharmaceuticals, Healthcare Technology may find it worthwhile to explore potential connections with Tom Flynn, as their portfolio suggests a familiarity and interest in this area.

Understanding Tom Flynn’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.